logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jonathan Wadsley

Sheffield Teaching Hospitals NHS Foundation Trust
H指数:35
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC plus FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trial

预后标志物、生活质量（QoL）和健康价值（V-He）在随机III期、多中心、开放标签的ABC-06临床试验中，接受二线单纯积极症状控制（ASC）或ASC联合奥沙利铂-5-FU化疗（ASC plus FOLFOX）治疗的晚期胆道癌（ABC）中的研究

ESMO Open
IF8.3
2026-06-010
OAAI
Lamarca, A.; Palmer, D. H.; Wasan, H. S.; Ross, P. J.; Ma, Y. T.; Arora, A.; Falk, S.; Gillmore, R.; Wadsley, J.; Patel, K.; Anthoney, A.; Maraveyas, A.; Iveson, T.; Waters, J. S.; Hobbs, C.; Macdonald, T.; Ryder, D.; Ramage, J.; Davies, L. M.; Bridgewater, J. A.; Valle, J. W.
Iodine or Not (IoN) for Low-risk Differentiated Thyroid Cancer: How should we implement the findings into UK practice? An expert consensus opinion

低风险分化型甲状腺癌的碘治疗与否（IoN）：我们应如何将研究结果应用于英国实践？专家共识意见

Clinical Oncology
IF3
2025-10-140
PRE
Kate Newbold; Nicola Armstrong; Matthew Beasley; Kate Farnell; Kate Garcez; Fahim Hassan; Shahid Iqbal; Vinidh Paleri; Nick Reed; Mark Strachan; Jonathan Wadsley; Allan Hackshaw; Ujjal Mallick
OC14 - Brain metastasis in differentiated thyroid cancer: an international multicentric retrospective analysis

OC14 - 分化型甲状腺癌脑转移：一项国际多中心回顾性分析

European Journal of Endocrinology
IF5.2
2025-09-220
OA
A Prinzi; E F van Velsen; A S Alzahrani; I Finkel; M L Gild; M A Habra; J Jan; J Krajewska; B Kiesewetter; A L Maia; R Liscak; R Paschke; F Pitoia; R Parameswaran; J Sheehan; C Spitzweg; M T Stegenga; J Wadsley; W G Kim; W T Zandee; W E Visser; F Frasca; P Malandrino
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer

患者报告的Selpercatinib耐受性对比卡博赞尼/Vandetanib：一项针对RET突变髓样甲状腺癌的LIBRETTO-531随机对照试验的二次分析

Thyroid
IF6.7
2025-08-180
PRE
Rossella Elisei; Lori J. Wirth; Jaume Capdevila; Ana Oliveira Hoff; Makoto Tahara; Eric J. Sherman; Mimi I. Hu; Ming-Hua Ge; Jonathan Wadsley; Fernanda Vaisman; Katerina Kopeckova; Jolanta Krajewska; Dinorath Olvera; Collin Churchill; Patricia Maeda; Adrienne M. Gilligan; Yan Lin; Nalin Payakachat; Bruce Robinson; Julien Hadoux; Marcia S. Brose
Assessing side-effect bother, burden, and tolerability: A qualitative study exploring the content validity of the Functional Assessment of Cancer Therapy – Item GP5

评估副作用困扰、负担和耐受性：一项探索癌症治疗功能评估量表GP5条目内容有效性的定性研究

Journal of Geriatric Oncology
IF2.7
2025-07-040
OA
Nalin Payakachat; Adrienne M. Gilligan; Danielle Altman; Patricia Maeda; Julia Choi; Shannon Bourke; Rebecca M. Speck; Erica Spies; Katerina Kopeckova; Rossella Elisei; Jonathan Wadsley; Jolanta Krajewska
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative

放射性核素治疗共识命名法：核医学全球倡议的初步建议

JOURNAL OF NUCLEAR MEDICINE
IF9.1
2025-03-270
PRE
Al-Ibraheem, Akram; Scott-, Andrew M.; Abdlkadir, Ahmed Saad; Vrachimis, Alexis; Lamoureux, Francois; Trujillo, Patricia Bernal; Bailey, Dale L.; More, Stuart; Giammarile, Francesco; Kumar, Rakesh; Nonnekens, Julie; Cutler, Cathy S.; Urbain, Jean-Luc C.; Dibble, Elizabeth H.; Sathekge, Mike Machaba; Bomanji, Jamshed; Cerci, Juliano J.; Thomas, Elizabeth; Small, William; Louw, Lizette; Hyun, O. Joo; Lee, Sze Ting; Nadel, Helen; Jacene, Heather; Watabe, Tadashi; Bom, Henry Hee-Seung; Bouyoucef, Salah Eddine; Weston, Charlotte; Wadsley, Jonathan; Irwin, Andy G.; Croasdale, Jilly; Zanzonico, Pat; Paez, Diana; Ghesani, Munir
Major secondary outcomes in the multicentre noninferiority randomised trial IoN: Is ablative radioiodine necessary for low-risk differentiated thyroid cancer patients?

多中心非劣效性随机试验IoN的主要次要结局: 对于低风险分化型甲状腺癌患者，消融性放射性碘是否必要？

ANNALS OF ONCOLOGY
IF65.4
2023-10-011
OAAI
Hackshaw, A.; Newbold, K.; Beasley, M.; Garcez, K.; Wadsley, J.; Johnson, S.; Stephenson, T.; Gaze, M. N.; Goodman, A.; Jeffries, S.; Wilkinson, D.; Macias, E.; Power, D.; Roques, T.; Speed, L.; Gerrard, G.; Forsyth, S.; Chang, E.; Farnell, K.; Mallick, U. K.
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma

NET-02: ni-iri/5-FU或多西他赛作为进行性低分化肺外神经内分泌癌患者二线治疗的随机，非比较，II期试验

ECLINICALMEDICINE
IF10
2023-06-018
OAAI
McNamara, Mairead G.; Swain, Jayne; Craig, Zoe; Sharma, Rohini; Faluyi, Olusola; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R.; Chau, Ian; Reed, Nick; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sothi, Sharmila; Anthoney, Alan; Bell, Christopher; Patel, Alkesh; Oughton, Jamie B.; Cairns, David A.; Mansoor, Wasat; Lamarca, Angela; Hubner, Richard A.; Valle, Juan W.

研究方向

暂未获取到该数据
K
Kate Newbold
H 指数:48论文数:359被引数:1.4万
J
Juan W. Valle
H 指数:87论文数:773被引数:5.0万
G
Glenn Flux
H 指数:42论文数:215被引数:6,178
H
Harpreet Wasan
H 指数:66论文数:431被引数:3.0万
L
Laura Moss
H 指数:14论文数:37被引数:2,628
K
Kate Garcez
H 指数:15论文数:82被引数:443
S
Sarah Brown
H 指数:39论文数:291被引数:6,292
G
Gary Middleton
H 指数:69论文数:465被引数:2.9万
M
Matthew Beasley
H 指数:18论文数:100被引数:1,470
Y
Yuk Ting
H 指数:25论文数:160被引数:6,675